Neutralizing antibodies in convalescent plasma are effective in SARS-CoV-2 clearance and induction of passive immunity. Also, non-neutralizing antibodies in convalescent plasma, such as IgM and IgG, could induce protective and/or therapeutic effects against COVID-19. The gene discussed is CD40LG; the disease is COVID-19.